Is the Exclusive Sale Rights a system only for top listed pharmaceutical companies?

The industry has paid attention on the pharmaceuticalamendment followed afteradoption the Patent Linkage System Sales Restriction Rights, which is pending in the National Assembly.

An argument has been raised that the ‘Exclusive Sale Rights System’ in the amendment will be a countermeasure against the Sales Restriction Rights while others argued that the system will only benefit top listed pha...